You are here

TauRx

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease

BioSpace

Mon, 07/24/23 - 09:57 am

neurodegenerative disease

Alzheimer's disease

Axsome Therapeutics

BrainStorm Cell Therapeutics

Seelos Therapeutics

Parkinson's Disease

Mitsubishi Tanabe Pharma

Huntington's disease

Prilenia Therapeutics

TauRx’s HMTM could be the first anti-tau disease-modifying drug for Alzheimer’s

Clinical Trials Arena

Tue, 10/11/22 - 04:17 pm

Alzheimer's disease

clinical trials

Significant readouts for small players

EP Vantage

Thu, 03/31/22 - 10:22 am

clinical trials

SAGE Therapeutics

Promising Alzheimer’s treatment flops in new trial, crushing hopes

Stat

Wed, 07/27/16 - 09:58 am

clinical trials

Alzheimer's disease

TauRx hits milestone in mild Alzheimer's trial

Pharmaphorum

Mon, 09/22/14 - 10:00 am

Alzheimer's disease

New drug studies offer patients hope of treatment to slow Alzheimer's within several years

Yahoo/AP

Mon, 12/3/12 - 10:21 am

Alzheimer's disease

BACE inhibitors

TauRx nabs $112M to back Phase III Alzheimer's program

Fierce Biotech

Tue, 11/20/12 - 01:32 pm

Alzheimer's disease